These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2996332)

  • 21. Comparison of enalapril and propranolol in essential hypertension.
    van Schaik BA; Geyskes GG; Kettner N; Boer P; Mees EJ
    Eur J Clin Pharmacol; 1986; 29(5):511-6. PubMed ID: 3007162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diurnal monitoring of blood pressure and the renin-angiotensin system in hypertensive patients on long-term angiotensin converting enzyme inhibition.
    Gadsbøll N; Damkjaer Nielsen M; Giese J; Leth A; Lønborg-Jensen H
    J Hypertens; 1990 Aug; 8(8):733-40. PubMed ID: 2170513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of increase in the enalapril dose and addition of hydrochlorothiazide as second-step treatment of hypertensive patients not controlled by enalapril alone.
    Sassano P; Chatellier G; Billaud E; Corvol P; Ménard J
    J Cardiovasc Pharmacol; 1989 Feb; 13(2):314-9. PubMed ID: 2468963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of combined therapy with amiloride and hydrochlorothiazide on plasma and total body potassium, blood pressure, and the renin-angiotensin-aldosterone system in hypertensive patients.
    Svendsen UG; Ibsen H; Rasmussen S; Leth A; Nielsen MD; Dige-Petersen H; Giese J
    Eur J Clin Pharmacol; 1986; 30(2):151-6. PubMed ID: 3519243
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative evaluation of enalapril and hydrochlorothiazide in elderly patients with mild to moderate hypertension.
    Gums JG; Lopez LM; Quay GP; Stein GH; McCarley DL
    Drug Intell Clin Pharm; 1988 Sep; 22(9):680-4. PubMed ID: 2850904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of enalapril in subjects with hypertension associated with moderate to severe renal dysfunction.
    Reams GP; Bauer JH
    Arch Intern Med; 1986 Nov; 146(11):2145-8. PubMed ID: 3022660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renin-angiotensin system phenotyping as a guidance toward personalized medicine for ACE inhibitors: can the response to ACE inhibition be predicted on the basis of plasma renin or ACE?
    Schilders JE; Wu H; Boomsma F; van den Meiracker AH; Danser AH
    Cardiovasc Drugs Ther; 2014 Aug; 28(4):335-45. PubMed ID: 24958603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double-blind comparison of captopril and enalapril in mild to moderate hypertension.
    Vlasses PH; Conner DP; Rotmensch HH; Fruncillo RJ; Danzeisen JR; Shepley KJ; Ferguson RK
    J Am Coll Cardiol; 1986 Mar; 7(3):651-60. PubMed ID: 3005384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enalapril in essential hypertension.
    Herrera-Acosta J; Pérez-Grovas H; Fernández M; Arriaga J
    Drugs; 1985; 30 Suppl 1():35-46. PubMed ID: 2994986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of enalapril and hydrochlorothiazide on the salt-induced cardiac and renal hypertrophy in normotensive rats.
    Mervaala EM; Laakso J; Vapaatalo H; Karppanen H
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Oct; 350(4):416-25. PubMed ID: 7845479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of effects of enalapril plus hydrochlorothiazide versus standard triple therapy on renal function in renovascular hypertension.
    Franklin SS; Smith RD
    Am J Med; 1985 Sep; 79(3C):14-23. PubMed ID: 2996342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enalapril blunts the antinatriuretic effect of circulating noradrenaline in man.
    Lang CC; Rahman AR; Balfour DJ; Struthers AD
    J Hypertens; 1993 May; 11(5):565-71. PubMed ID: 8390529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of firibastat in combination with enalapril and hydrochlorothiazide on blood pressure and vasopressin release in hypertensive DOCA-salt rats.
    Marc Y; Hmazzou R; De Mota N; Balavoine F; Llorens-Cortes C
    Biomed Pharmacother; 2021 Aug; 140():111682. PubMed ID: 34020248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril.
    Nussberger J; Wuerzner G; Jensen C; Brunner HR
    Hypertension; 2002 Jan; 39(1):E1-8. PubMed ID: 11799102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy and safety of enalapril in moderate to severe essential hypertension.
    Walker JF; Kulaga SF; Kramsch DM
    J Hypertens Suppl; 1984 Dec; 2(2):S107-11. PubMed ID: 6100871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversal of cardiovascular structural changes when treating essential hypertension. The importance of the renin-angiotensin-aldosterone system.
    Dahlöf B; Herlitz H; Aurell M; Hansson L
    Am J Hypertens; 1992 Dec; 5(12 Pt 1):900-11. PubMed ID: 1337459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enalapril and pressure-diuresis in hypertensive rats transgenic for mouse renin gene.
    Springate J; Van Liew J; Ganten D
    Kidney Blood Press Res; 1997; 20(1):1-5. PubMed ID: 9192903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of reduction in microalbuminuria by enalapril and hydrochlorothiazide in normotensive patients with insulin dependent diabetes.
    Hallab M; Gallois Y; Chatellier G; Rohmer V; Fressinaud P; Marre M
    BMJ; 1993 Jan; 306(6871):175-82. PubMed ID: 8443481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renal and endocrine effects of long-term converting enzyme inhibition as compared with calcium antagonism in essential hypertension.
    Katzman PL; Henningsen NC; Fagher B; Thulin T; Hulthén UL
    J Cardiovasc Pharmacol; 1990 Mar; 15(3):360-4. PubMed ID: 1691357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.